SCHEMBL3058083

SCHEMBL3058083

FC(F)(F)c1ccccc1-c1nccs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
TDP1 Q9NUW8 3/20 0.51
PDPK1 O15530 1/20 0.48
HSD11B1 P28845 2/20 0.46
P2RX7 Q99572 1/20 0.46
CYP1A2 P05177 6/20 0.45
TSHR P16473 5/20 0.45
CYP2C19 P33261 5/20 0.45
CYP3A4 P08684 5/20 0.45
CYP2D6 P10635 4/20 0.45
GBA1 P04062 1/20 0.45
S1PR1 P21453 1/20 0.43
HIF1A Q16665 2/20 0.42
USP2 O75604 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
NPY5R Q15761 1/20 0.41
KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27763733 0.83 PDPK1 (0.43) ALDH1A1TDP1PDPK1HSD11B1P2RX7
SCHEMBL17030749 0.82 PDPK1 (0.48) ALDH1A1TDP1PDPK1P2RX7S1PR1
SCHEMBL5692672 0.80 PDPK1 (0.64) ALDH1A1PDPK1TSHRHSD17B10RAB9A
SCHEMBL10586520 0.80 S1PR1 (0.43) ALDH1A1TDP1PDPK1HSD11B1P2RX7
SCHEMBL19695750 0.79 PDPK1 (0.46) ALDH1A1TDP1PDPK1P2RX7S1PR1
SCHEMBL12503020 0.79 PARP1 (0.46) ALDH1A1TDP1P2RX7S1PR1KMO
SCHEMBL1951149 0.78 PDPK1 (0.61) ALDH1A1PDPK1TSHRHSD17B10RAB9A
SCHEMBL8567274 0.77 PDPK1 (0.55) ALDH1A1TDP1PDPK1RAB9AKDM4E
SCHEMBL20114914 0.77 PDPK1 (0.43) ALDH1A1TDP1PDPK1P2RX7S1PR1
SCHEMBL30278504 0.77 S1PR1 (0.43) ALDH1A1TDP1PDPK1HSD11B1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108373476-B Kinase inhibitor and preparation and application thereof 成都地奥制药集团有限公司 2021-06-01 CN disclosed
CN-108373476-A A kind of kinase inhibitor and its preparation and application 成都地奥制药集团有限公司 2018-08-07 CN disclosed
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267697-A1 ION CHANNEL MODULATORS CACNA1E, CACNA1A, CACNA1S ALDH1A1 957/4885TDP1 4347/4885PDPK1 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.